© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 12, 2020
Stephen J. Freedland, MD, discusses remaining questions with the real-world utility of enzalutamide in prostate cancer.
May 11, 2020
March 27, 2020
Stephen J. Freedland, MD, discusses how real-world evidence with the use of enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) compares with data from the phase III PREVAIL trial.
March 10, 2020
Stephen J. Freedland, MD, discusses the importance of conducting real-world analyses in prostate cancer.